Practice Locations

map pinmap pin

About Zachary T. Berman, MD

Zachary T. Berman, MD is an interventional radiologist who performs minimally invasive image-guided procedures. He specializes in liver-directed therapies for hepatocellular carcinoma and metastatic liver disease such as transarterial radioembolization (TARE/SIRT), transarterial chemoembolization (TACE), and percutaneous ablation (microwave, radiofrequency and cryoablation). He also focuses on the treatment of vascular malformations (arteriovenous malformations and venous malformations) as well as neuroendocrine tumors.

Dr. Berman enjoys using a multidisciplinary approach and works collaboratively with physicians in various specialties to determine the best care path for his patients.

As an assistant professor at UC San Diego School of Medicine, he instructs medical students, residents, and fellows in the Department of Radiology. Dr. Berman finds mentoring future clinicians and leaders in interventional radiologists extremely rewarding.

He is energized by the ability to conduct cutting-edge research to expand and improve the delivery of minimally invasive procedures. Dr. Berman is actively engaged in clinical trials directed toward primary and metastatic liver disease treatments, specifically the improved use of Yttrium 90 Radioembolization.

He completed an internship and interventional radiology residency at UC San Diego School of Medicine, where he was the first integrated interventional radiology resident graduate. Dr. Berman was chief diagnostic radiology resident in 2018-2019 and chief interventional radiology resident in 2019-2020. He earned his medical degree from Case Western Reserve University School of Medicine in Cleveland, Ohio.

Dr. Berman is a member of the Society of Interventional Radiology, the Society of Interventional Oncology and the Radiologic Society of North America.

In his free time, he enjoys running, hiking and astrophotography.

UC San Diego Health Links
For more information, see Liver Cancer and Neuroendocrine Cancer.

Insurance Information
UC San Diego Health accepts most major health insurance plans, but you should verify that your plan covers this provider and all services and locations. The information in the link below does not apply to affiliate providers, who are not employed by UC San Diego Health.
Health Insurance Plans Accepted
Open Payments Program Notification
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
View Open Payments data for Dr. Berman

Medical Degree

  • Case Western Reserve University School of Medicine, Cleveland, OH

Residency

  • UC San Diego School of Medicine, San Diego, CA

Gender

  • Male

Date Joined Staff

  • 2020-07-01

Conditions and Treatments

  • Hepatocellular Carcinoma (HCC)
  • Metastatic Liver Disease
  • Image-Guided Procedures
  • Minimally Invasive Approach
  • Chronic Liver Disease
  • Vascular Malformations
  • Venous Malformations
  • Arteriovenous Malformations
  • Percutaneous Ablation
  • Transarterial Chemoembolization (TACE)
  • Transarterial Radioembolization (TARE)
  • Yttrium-90 Radioembolization
  • Liver Cancer
  • Neuroendocrine Tumors
Insurance Information
UC San Diego Health accepts most major health insurance plans, but you should verify that your plan covers this provider and all services and locations. The information in the link below does not apply to affiliate providers, who are not employed by UC San Diego Health.
Health Insurance Plans Accepted
Open Payments Program Notification
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
View Open Payments data for Dr. Berman